P. Ringwald et al., In vitro activity of dihydroartemisinin against clinical isolates of Plasmodium falciparum in Yaounde, Cameroon, AM J TROP M, 61(2), 1999, pp. 187-192
Citations number
48
Categorie Soggetti
Envirnomentale Medicine & Public Health","Medical Research General Topics
The in vitro activities of dihydroartemisinin (the biologically active meta
bolite of artemisinin derivatives), chloroquine, monodesethylamodiaquine (t
he biologically active metabolite of amodiaquine), quinine, mefloquine, hal
ofantrine, and pyrimethamine were assessed in 65 African isolates of Plasmo
dium falciparum from Yaounde, Cameroon using an isotopic microtest. The 50%
inhibitory concentration (IC50) values for dihydroartemisinin were within
a narrow range from 0.25 to 4.56 nM, with a geometric mean of 1.11 nM (95%
confidence interval = 0.96-1.28 nM). Dihydroartemisinin was equally active
(P > 0.05) against the chloroquine-sensitive isolates (geometric mean IC50
= 1.25 nM, 95% confidence interval = 0.99-1.57 nM) and the chloroquine-resi
stant isolates (geometric mean IC50 = 0.979 nM, 95% confidence interval = 0
.816-1.18 nM). A significant positive correlation was observed between the
responses to dihydroartemisinin and mefloquine (r = 0.662) or halofantrine
(r = 0.284), suggesting in vitro cross-resistance. There was no correlation
between the responses to dihydroartemisinin and other antimalarial drugs.